Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Molecular Pharmaceutics|June 14, 2018
Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab FragmentCheng Zhang, Maariyah Samad, Haoran Yu, et al.
Molecular Pharmaceutics|December 23, 2015
Mapping the Aggregation Kinetics of a Therapeutic Antibody FragmentNesrine Chakroun, David Hilton, Shahina S Ahmad, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 13, 2006
Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodiesMaria E Farrugia, Robin P Kennett, David Hilton-Jones, et al.
Brain : a Journal of Neurology|April 27, 2010
Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutationsHoma Tajsharghi, David Hilton-Jones, Olayinka Raheem, et al.
Neuromuscular Disorders : NMD|November 3, 2010
Oculopharyngodistal myopathy--a possible association with cardiomyopathyWesley Thevathasan, Waney Squier, David H MacIver, et al.
The American Journal of Cardiology|May 12, 2004
Comparison of treatment outcomes in patients > or =80 years undergoing transradial versus transfemoral coronary interventionW Peter Klinke, J David Hilton, Rebecca N Warburton, et al.
Acta Neuropathologica|April 11, 2014
FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansionDirk Bäumer, Simon Z East, Bing Tseu, et al.
Annals of the New York Academy of Sciences|November 10, 2017
The Association of British Neurologists' myasthenia gravis guidelinesJon Sussman, Maria E Farrugia, Paul Maddison, et al.
Pageof 12